9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Nowadays, data indicate that antimicrobial peptides play an important role in immunological defense. Human cathelicidin LL-37 possesses a broad spectrum of antimicrobial properties against Gram-positive and Gram-negative bacteria, and is thereby an important component of defense mechanisms within the respiratory tract. In this study, we determined the LL-37 serum level in patients with pneumonia caused by different bacteria species in comparison with healthy subjects. Twenty-two patients with pneumonia caused by coccal Gram-positive bacteria (I), 16 patients with pneumonia caused by Haemophilus influenzae (II), 29 patients with pneumonia caused by members of the Enterobacteriaceae (III), 13 patients caused by non-fermenting Gram-negative bacteria (IV), and 30 healthy controls were enrolled in the study. Serum LL-37 concentration was measured using an enzyme-linked immunosorbent assay (ELISA). The mean LL-37 concentration in pneumonia patients was significantly higher in group I (p = 0.0032), group II (p = 0.0022), and group III (p = 0.019), and significantly lower in group IV (p = 0.000004) as compared with healthy volunteers. Our data suggest that LL-37 plays an important role in defense mechanisms during pneumonia. The reduced level of this peptide in subjects with pneumonia caused by opportunistic bacteria may reflect weakened immune system reactivity in these patients.

          Related collections

          Most cited references29

          • Record: found
          • Abstract: found
          • Article: not found

          The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations.

          We identified antibacterial components in human T and natural killer (NK) cells by using freshly isolated lymphocytes enriched for T and NK cells as starting material. After growing these lymphocytes for 5 days in the presence of interleukin (IL)-2, we isolated and characterized several antibacterial peptides/proteins from the supernatant-alpha-defensins (HNP 1-3), LL-37, lysozyme, and a fragment of histone H2B-although other active components were also present. We then used reverse transcriptase-polymerase chain reaction to search for expression of the gene coding for LL-37 in several B-cell lines, gammadelta T-cell lines, NK clones, and one monocytic cell line, with positive results, but found no expression in several alphabeta T-cell lines. The alpha-defensins (HNP 1-3) were also found to be expressed in several of these cell lines. To confirm the presence of these antibacterial peptides in lymphocytes, we localized them to NK, gammadelta T cells, B cells, and monocytes/macrophages by using double-staining immunohistochemical analysis of freshly isolated lymphocytes. We also found that primary cultures of lymphocytes transcribe and secrete LL-37 and that these processes are affected by IL-6 and interferon-gamma. In addition, we demonstrated that LL-37 has chemotactic activity for polymorphonuclear leukocytes and CD4 T lymphocytes, whereas others have shown chemotactic activity for human alpha-defensins (HNP 1-2). These findings suggest that microbicidal peptides are effector molecules of lymphocytes and that antibacterial activity previously shown to be derived from T and NK cells may be partly mediated by the antibacterial peptides LL-37 and HNP 1-3.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons

            Plasmacytoid DCs (pDCs) are a rare population of circulating cells specialized in the production of large amounts of type I IFNs (IFN-α/β) in response to viral infections (Cella et al., 1999; Siegal et al., 1999). This ability is linked to their unique intracellular expression of toll-like receptor (TLR) 7 and TLR9 (Kadowaki et al., 2001), which recognize single-stranded (ss) viral RNA and DNA transported into endosomal compartments by the virus infecting the cell (Hemmi et al., 2000, 2002; Diebold et al., 2004; Heil et al., 2004). IFN-α/β produced by pDCs was shown to be critical in inhibiting viral replication but also to contribute to the induction and expansion of an antiviral immune response by activating memory T cells, B cells, and NK cells (Theofilopoulos et al., 2005; Gilliet et al., 2008). Under steady-state conditions, pDCs are present in the blood stream and secondary lymphoid organs but are normally absent from most peripheral tissues including the skin (Wollenberg et al., 2002; Gilliet et al., 2004). pDCs can, however, infiltrate the skin infected by viruses including varicella zoster virus (Gerlini et al., 2006), human papillomavirus (Vanbervliet et al., 2003), and herpes simplex virus (Donaghy et al., 2009). These skin-infiltrating pDCs were found to produce IFN-α/β, which is consistent with the ability of viruses to infect pDCs and deliver their nucleic acid cargo into intracellular TLR7/9 compartments of pDCs. Surprisingly, large numbers of pDCs have also been found in the skin of patients with psoriasis (Wollenberg et al., 2002; Gilliet et al., 2004; Nestle et al., 2005), a chronic inflammatory disease of the skin mediated by autoimmune T cells. In psoriatic skin, pDCs are chronically activated to produce IFN-α/β, a process which triggers the activation and expansion of autoimmune T cells leading to the epidermal hyperproliferation and the formation of psoriasis (Nestle et al., 2005). We have recently found that pDC activation in psoriatic skin is driven by the human cathelicidin antimicrobial peptide known as LL37 (Lande et al., 2007). LL37 was found to convert otherwise inert extracellular host-derived (self) nucleic acids, into a potent trigger of pDC activation by forming a complex with the self-RNA and self-DNA and by transporting them into intracellular TLR7 and TLR9 compartments (Lande et al., 2007; Ganguly et al., 2009). The cathelicidin peptide is usually not expressed in healthy skin but was found to be continuously overexpressed by keratinocytes of psoriatic skin, providing an explanation for the chronic activation of pDCs in psoriasis (Lande et al., 2007). Interestingly, the expression of cathelicidin peptides can be transiently induced in keratinocytes by common skin injury (Dorschner et al., 2001; Schauber et al., 2007). However, whether skin injury is associated with pDC infiltration and activation to produce IFN-α/β is not known. In this paper, we found that skin injury induces an early and short-lived infiltration of pDCs into skin wounds. These pDCs were activated to produce IFN-α/β through TLR7 and TLR9, indicating that they recognize self-nucleic acids released by damaged cells in skin wounds. Cathelicidin gene expression closely paralleled pDC activation and cathelicidin peptides were found to be sufficient to induce IFN-α/β production by pDC in the skin. However, cathelicidins were not required to induce IFN-α/β expression, suggesting a redundancy of this pathway for pDC activation in injured skin. Depletion of pDCs or inhibition of IFN-α/β receptor signaling significantly impaired the acute inflammatory cytokine response and delayed reepithelization of skin wounds. These data uncover a novel role of pDCs in sensing nucleic acids in wounded skin and demonstrate their involvement in the acute inflammatory response and wound healing through their production of IFN-α/β. RESULTS Skin injury induces a rapid infiltration of pDCs To determine whether injury of normal skin induces infiltration and activation of pDCs, we adopted a mechanical skin injury model based on tape stripping of shaved murine skin (Sano et al., 2005; Jin et al., 2009). This procedure mechanically removes the upper epidermal layers and injures the basal layer, leading to an acute inflammatory response and reepithelization of the skin (Wojcik et al., 2000). We found that tape stripping induced a robust dermal influx of leukocytes reaching a peak between 24 and 48 h after skin injury (Fig. 1, A and B). Analysis of single cell suspensions revealed that, 24 h after skin injury, the majority of cells infiltrating the dermis were Gr-1+CD11b+ neutrophils (mean, 37.8%; range, 31–42.9%; Fig. 1 C). Interestingly, a large number of pDCs, detected as PDCA1+B220+ cells, also infiltrated the dermis 24 h after injury (mean, 14.4%; range, 3.7–28%; Fig. 1, C and D). The pDC identity was confirmed by showing that these cells coexpressed CD11c, MHC class II molecules, and the pDC-specific marker Siglec-H (Zhang et al., 2006; Fig. 1 E) and lacked common lineage markers CD3, CD19, and CD11b (not depicted). Furthermore, immunohistochemistry for Siglec-H showed that these cells had typical lymphocytic morphology (Fig. 1 F). The accumulation of pDCs and neutrophils in skin wounds was rapid and transient, as they accumulated at 24 h but returned to preinjury levels after 48 h. In contrast, CD3+ T cells were constitutively present in uninjured skin, and increased in number at a later time point (48 h after injury; Fig. 1, C and D). Conventional DCs in the dermal compartment of injured skin were detected as CD11c+PDCA1− cells, and their number did not increase but, rather, showed a tendency toward a decrease (Fig. S1), potentially reflecting their activation and migration to lymph nodes as previously reported (Holzmann et al., 2004). Thus, skin injury induces a rapid and robust infiltration of pDCs that parallels the early wound infiltration by neutrophils. Figure 1. Rapid infiltration of pDCs into injured skin. (A) Representative image of shaved murine back skin 24 h after tape stripping. (B) Dermal cell suspensions isolated from skin at various times after injury and viable cells were counted. The mean number of cells ± SEM per cm2 of injured skin is given and represent data from five mice over a 3-d time course. (C) The percentage of pDCs (B220+PDCA-1+), neutrophils (Gr-1+CD11b+), and T cells (CD3+) in dermal single cell suspensions isolated from injured skin was measured by flow cytometry. Data are the mean ± SEM of five mice per each time point. (D) Flow cytometry plot of pDC, neutrophils, and T cells in injured skin over a 3-d time course. Data are representative of five mice. The percentage of each population is shown in the plots. (E) Flow cytometry for CD11c, IA/IE, and Siglec H surface expression on B220+PDCA-1+ pDC 24 h after skin injury. (F) Representative immunohistochemical staining for Siglec H in injured skin collected 24 h after tape stripping. Bars: (main image) 50 µm; (inset) 10 µm. Data in A–F are representative of two independent experiments. Skin injury induces a transient activation of pDCs to produce type I IFNs Because pDCs are specialized producers of IFN-α/β, producing 100–1,000× more than any other cell type (Siegal et al., 1999), we sought to investigate whether pDCs infiltrating injured skin are activated to produce IFN-α/β. First, we isolated total skin from mice at different time points after injury and performed gene expression analysis. mRNA expression levels of both IFN-α2 (Fig. 2 A) and IFN-β (not depicted) was undetectable in normal skin before injury but rapidly induced by skin injury. Both IFN-α2 and IFN-β (unpublished data) mRNA expression levels reached a peak 24 h after injury and rapidly declined thereafter. This expression profile closely paralleled the presence of pDCs, suggesting that pDCs are the main source of IFN-α/β in injured skin (Fig. 1 C and Fig. 2 A). In contrast, the expression of the inflammatory cytokines IL-6 and TNF showed a distinct time course. IL-6 mRNA expression reached a peak 6 h after injury (Fig. 2 A), which is consistent with injured keratinocytes as an early source of this cytokine (Sehgal, 1990). TNF was induced 24 h after injury but its expression was sustained for up to 72 h (Fig. 2 A), suggesting that cell types other than pDCs are a major source of this cytokine. To confirm the role of pDCs as principal producers of IFN-α/β in injured skin, we depleted pDCs by treating mice with antibodies recognizing BST-2, a transmembrane protein specifically expressed on resting mouse pDCs (Blasius et al., 2006). Two injections of these antibodies at 48 and 24 h before skin injury efficiently depleted pDCs (Fig. S2), as previously reported (Krug et al., 2004; Yoneyama et al., 2005; Blasius et al., 2006; Kuwajima et al., 2006). pDC depletion completely inhibited the accumulation of pDC in injured skin (not depicted) and abrogated the induction of IFN-α2 (Fig. 2 B) and IFN-β (not depicted) expression at 24 h, confirming that pDCs are the principal source of IFN-α/β in injured skin. Interestingly, pDC depletion partially affected the expression of IL-6, whereas the expression of TNF was not affected at 24 h after injury. Because the infiltration of pDCs into injured skin is paralleled by the infiltration of neutrophils, we next sought to determine the role of neutrophils in the expression of these cytokines. Neutrophil depletion using a Ly6G-specific antibody did not show significant effect on the expression of IFN-α/β and IL-6 (Fig. 2 B) but significantly decreased the expression of TNF (Fig. 2 B), which is consistent with neutrophils being a main early source of this cytokine (Dubravec et al., 1990; Hübner et al., 1996). These data demonstrate that skin injury induces early infiltration of pDCs and their local activation to produce IFN-α/β. Figure 2. pDCs are transiently activated to produce type I IFNs in injured skin. (A) Time course analysis of IFN-α, IL-6, and TNF mRNA tissue expression in injured skin. The data are given as fold induction over time 0 and represent the mean ± SEM of five mice per time point. (B) Relative IFN-α, IL-6, and TNF mRNA tissue expression of uninjured skin or injured skin collected 24 h after tape stripping of pDC-depleted, neutrophil-depleted, or control IgG-treated mice. Data represent the mean ± SEM of five mice per group. *, P = 0.001; **, P = 0.02; ***, P 90%. 50,000 cells were cultured overnight in RPMI-based media (10% FCS, 50 µM β-mercaptoethanol, pen/strep, glutamine, sodium pyruvate, and Hepes). The supernatants were used to determine IFN-α protein secretion using a commercial Elisa kit (PBL). As a source of DNA, we used synthetic phosphodiesteric CpG-containing oligonucleotides hybridized to its complementary strand to mimick natural mammalian DNA fragments. 0.3 µM dsDNA was mixed with 30 µM cathelicidin peptides in a volume of 20 µl for 30 min at room temperature. Online supplemental material. Fig. S1 shows the kinetics of mDCs in the skin after skin injury. Fig. S2 shows the efficiency of pDC depletion in the spleen over a 5-d period using BST-specific monoclonal antibodies. Fig. S3 shows the role of TLR7 and TLR9 in the expression of type I IFN, IL-6, and TNF induced by skin injury. Fig. S4 shows the role of MyD88 and TLR7/9 in the induction of IL-6 and TNF in injured skin. Fig. S5 shows the role of MyD88 in the induction of T cell–derived IL-17A, IL-22, and IFN-γ in injured skin. Online supplemental material is available at http://www.jem.org/cgi/content/full/jem.20101102/DC1.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization.

              Dendritic cells (DC) are instrumental in orchestrating an appropriately polarized Th cell response to pathogens. DC exhibit considerable phenotypic and functional plasticity, influenced by lineage, Ag engagement, and the environment in which they develop and mature. In this study, we identify the human cationic peptide LL-37, found in abundance at sites of inflammation, as a potent modifier of DC differentiation, bridging innate and adaptive immune responses. LL-37-derived DC displayed significantly up-regulated endocytic capacity, modified phagocytic receptor expression and function, up-regulated costimulatory molecule expression, enhanced secretion of Th-1 inducing cytokines, and promoted Th1 responses in vitro. LL-37 may be an attractive therapeutic candidate for manipulating T cell polarization by DC.
                Bookmark

                Author and article information

                Journal
                Cent Eur J Immunol
                Cent Eur J Immunol
                CEJI
                Central-European Journal of Immunology
                Polish Society of Experimental and Clinical Immunology
                1426-3912
                1644-4124
                31 December 2018
                2018
                : 43
                : 4
                : 453-457
                Affiliations
                [1 ]Department of Experimental Immunology, Medical University of Lodz, Lodz, Poland
                [2 ]Pulmonary Disease Hospital, Lodz, Poland
                Author notes
                Correspondence: Prof. Ewa Brzezińska-Błaszczyk, Department of Experimental Immunology, Medical University of Lodz, 251 Pomorska St., 92-213 Lodz, Poland. e-mail: ewab@ 123456csk.umed.lodz.pl
                Article
                81355
                10.5114/ceji.2018.81355
                6384432
                30799994
                eb7b938d-9450-4f57-8b0c-63750b925dd5
                Copyright: © 2018 Polish Society of Experimental and Clinical Immunology

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

                History
                : 07 April 2017
                : 12 June 2017
                Categories
                Clinical Immunology

                pneumonia,immune system,antimicrobial peptides,cathelicidin ll-37,host defense

                Comments

                Comment on this article